⌘K

Login Start Free

Home/Companies/CIK 0001974915

V

ISSUER//CIK 0001974915

Vestal Point Capital, LP

other

Exchange

—

Entity type

other

Fiscal year end

Dec 31

Headquarters

DE

Recent Filings

10 items

SCHEDULE 13G/A
Taysha Gene Therapies, Inc.
May 15, 5:09 PM ET·0000902664-26-002553
10.9 KB
SCHEDULE 13G/A
Bicara Therapeutics Inc.
May 15, 5:06 PM ET·0000902664-26-002552
10.8 KB
SCHEDULE 13G/A
Enliven Therapeutics, Inc.
May 15, 5:05 PM ET·0000902664-26-002551
10.9 KB
SCHEDULE 13G/A
Alto Neuroscience, Inc.
May 15, 5:05 PM ET·0000902664-26-002550
10.8 KB
SCHEDULE 13G/A
Immatics N.V.
May 15, 5:03 PM ET·0000902664-26-002549
10.9 KB
SCHEDULE 13G/A
Arcellx, Inc.
May 15, 5:03 PM ET·0000902664-26-002548
10.2 KB
SCHEDULE 13G/A
Day One Biopharmaceuticals, Inc.
May 15, 5:02 PM ET·0000902664-26-002547
10.5 KB
SCHEDULE 13G
BRIGHT MINDS BIOSCIENCES INC.
May 15, 5:02 PM ET·0000902664-26-002546
15.2 KB
SCHEDULE 13G
Nurix Therapeutics, Inc.
May 15, 5:01 PM ET·0000902664-26-002545
15.2 KB
SCHEDULE 13G
Aprea Therapeutics, Inc.
May 15, 5:00 PM ET·0000902664-26-002544
17.3 KB

Insiders

0

No insiders on record

Tickers

No tickers on record

Addresses

business
632 BROADWAY SUITE 602
NEW YORK, NY, 10012
mailing
632 BROADWAY SUITE 602
NEW YORK, NY, 10012